{
    "clinical_study": {
        "@rank": "75577", 
        "arm_group": {
            "arm_group_label": "chronic obstructive pulmonary disease", 
            "description": "More than 12 million adults are diagnosed with COPD\nCOPD is the 4th leading cause of death in the U.S.\nBreathing difficulty is the major reason patients seek medical attention\nCOPD patients requiring hospitalization were associated with higher costs\nOximetry is an important tool for assessing need for Long-term oxygen therapy\nLTOT has been proven to improve survival and quality of life\nPatients will be provided a lightweight portable oxygen concentrator to:\nsupport increased activity\nimprove quality of life\nincrease functional capacity"
        }, 
        "brief_summary": {
            "textblock": "-  Evaluate subjects in an prospective observational study\n\n        -  Subjects will be administered scientifically validated questionnaires\n\n        -  Determine the affect of the Portable Oxygen Concentrator (POC) on improvements in:\n\n             1. Exercise capability, dyspnea and quality of life as primary endpoints\n\n             2. Utilize:\n\n                  1. Baseline Dyspnea Index (BDI)\n\n                  2. Transitional Dyspnea Index (TDI)\n\n                  3. Chronic Respiratory Disease Questionnaire (CRQ)\n\n                  4. Six minute walk test (6MWT)\n\n                  5. Epworth Sleepiness Scale (ESS)\n\n        -  The secondary endpoints will be:\n\n             1. Rate of exacerbations, sleep quality\n\n             2. Health care utilization (emergency room encounters, hospital admissions)"
        }, 
        "brief_title": "Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "COPD", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Evaluate subjects in an prospective observational study in which subjects will be screened\n      and administered scientifically validated questionnaires at study entry and during the\n      observation period at specified intervals to determine the affect of the Portable Oxygen\n      Concentrator on improvements in exercise capability, dyspnea and quality of life as primary\n      endpoints, utilizing the Baseline Dyspnea Index (BDI), Transitional Dyspnea Index (TDI), the\n      Chronic Respiratory Disease Questionnaire (CRQ) and six minute walk test (6MWT). The\n      secondary endpoints will be rate of exacerbations, sleep quality (reported as number of\n      hours sleep improvement; utilize Epworth Sleepiness Scale [ESS]), and health care\n      utilization (emergency room encounters, hospital admissions)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary diagnosis of chronic obstructive pulmonary disease (COPD)\n\n          -  Clinically stable disease at the time of consent\n\n          -  Current prescription of oxygen; with previous or current oximetry suggesting\n             desaturation at rest or during exercises (oxygen saturation \u226488% on at least one\n             occasion)\n\n          -  Highest measured FEV1, 70% predicted; and\n\n          -  Highest measured FEV1/FVC, 70% predicted\n\n          -  Capable of giving informed consent\n\n          -  Currently using oxygen system that is either a portable tank; liquid or other\n             Portable Oxygen Concentrator (POC)\n\n          -  Mobility without a walker, cane or rollator\n\n          -  Spo2 \u2265 92% on Portable Oxygen Concentrator (POC) at rest and activity\n\n          -  Non-smoker at time of consent\n\n        Exclusion Criteria:\n\n          -  Cardiovascular disease as defined in New York Heart Association Functional Class III\n\n          -  Degenerative bone or joint disease that limits mobility and ability to perform\n             activities of daily living and/or exercise\n\n          -  Current homeless persons\n\n          -  Active drug/alcohol dependence\n\n          -  Recent abuse history within the past two years\n\n          -  Clinically unstable at the time of consent\n\n          -  Currently a tobacco smoker"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "65 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "COPD Patients prescreened and selected by their primary care physician or pulmonologist"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948544", 
            "org_study_id": "01053013A"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "COPD", 
            "LTOT", 
            "Long-Term Oxygen Therapy", 
            "Portable Oxygen Concentrator", 
            "Quality of Life", 
            "Six Minute Walk Distance Test"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Mark Yamanaka, MD", 
                    "phone": "760-941-0221"
                }, 
                "facility": {
                    "address": {
                        "city": "Oceanside", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92054"
                    }, 
                    "name": "Tri-City Pulmonary Medical Group"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jeffrey Newman, MD", 
                    "phone": "760-941-8888"
                }, 
                "contact_backup": {
                    "last_name": "Patty Newman", 
                    "phone": "760-941-8888"
                }, 
                "facility": {
                    "address": {
                        "city": "Vista", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92083"
                    }, 
                    "name": "Cardinal Medical Group"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Khaled Chan", 
                    "phone": "714-379-3221"
                }, 
                "facility": {
                    "address": {
                        "city": "Westminster", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92683"
                    }, 
                    "name": "Pathway Medical Group"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Study to Evaluate Improvement in the Quality of Life and Outcomes of Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)", 
        "overall_contact": {
            "email": "vernonpertelle@stratihealth.com", 
            "last_name": "Vernon R Pertelle, MBA, RRT", 
            "phone": "760-473-0368"
        }, 
        "overall_contact_backup": {
            "email": "lauriestewartsd@aol.com", 
            "last_name": "Laurie Sterwart, LPT, CRCC", 
            "phone": "858-829-7770"
        }, 
        "overall_official": {
            "affiliation": "Tri-City Medical Center", 
            "last_name": "Isabel Pereira, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Change in functional capability, dyspnea - BDI/TDI\nChange in exercise capability - 6MWT", 
                "measure": "Functional Capacity", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Quality of life - CRQ", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "6 Months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948544"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "StratiHealth", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "StratiHealth", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}